Comments on: AstraZeneca: CALLA Phase III Trial for Imfinzi fails to achieve statistical significance https://ukinvestormagazine.co.uk/astrazeneca-calla-phase-iii-trial-for-imfinzi-failed-to-achieve-statistical-significance/ UK Investor Magazine provides breaking financial news and investment ideas Thu, 24 Mar 2022 12:38:30 +0000 hourly 1 https://wordpress.org/?v=6.9.4 By: FTSE 100 rises with oil prices at $121 – Ali Tech https://ukinvestormagazine.co.uk/astrazeneca-calla-phase-iii-trial-for-imfinzi-failed-to-achieve-statistical-significance/#comment-17352 Thu, 24 Mar 2022 12:38:30 +0000 https://ukinvestormagazine.co.uk/?p=48490#comment-17352 […] AstraZeneca saw shares gain 0.65% despite unoptimistic results from their CALLA Phase III trial with Imfiniza. […]

]]>